Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lifen Ren"'
Publikováno v:
Clinical Laboratory; 2024, Vol. 70 Issue 8, p1452-1456, 5p
Autor:
Jingying Nong, Xi Li, Deruo Liu, Quan Zhang, Jia-lin Lü, Huiyi Yang, Lifen Ren-Heidenreich, Shucai Zhang, Yi-fen Sun, Na Qin, Shanqing Li, Xinjie Yang, Yuhua Wu, Hui Zhang, Yong-Qing Zheng, Xinyong Zhang
Publikováno v:
The Journal of Molecular Diagnostics. 15:819-826
Somatic DNA mutations affecting the epidermal growth factor receptor (EGFR) signaling pathway are known to predict responsiveness to EGFR-tyrosine kinase inhibitor drugs in patients with advanced non-small-cell lung cancers. We evaluated a sensitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed9f58532fb93fd444fefe13da4f538
https://doi.org/10.1016/j.jmoldx.2013.06.006
https://doi.org/10.1016/j.jmoldx.2013.06.006
Publikováno v:
cclm. 48:1103-1106
Background: Somatic mutations in the KRAS gene have been reported to confer drug resistance to epidermal growth factor receptor tyrosine kinase inhibitors and some monoclonal antibodies. However, current DNA mutation detection technologies are primar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3f6b5b75787aa2e2e3a3c9c6bb771e
https://doi.org/10.1515/cclm.2010.227
https://doi.org/10.1515/cclm.2010.227
Publikováno v:
Acta biochimica et biophysica Sinica. 46(6)
A single nucleotide polymorphism (SNP) is the most frequent type of variation in the genome. There are around 10 million SNPs that have been identified in the human genome [1]. Because SNPs are highly conserved throughout evolution and within a popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692e58d7e5f1a874674c83b2f965bce8
https://pubmed.ncbi.nlm.nih.gov/24785331
https://pubmed.ncbi.nlm.nih.gov/24785331
Autor:
Susumu Suzuki, Makoto Yazaki, Masakazu Nitta, Kazuya Tsuboi, Seiji Kojima, Lifen Ren, Taiji Kato, Shinsuke Harada, Shogo Banno, Humping Ni, Hirokazu Komatsu, Ryuzo Ueda, Atsushi Wakita
Publikováno v:
Cancer Letters. 124:173-180
We studied the feasibility of the clinical application of a new bcr/abl analysis system, C-TRAK t(9;22), consisting of a multiplex RT-PCR and a colormetric assay. With this system, bcr/abl transcripts could be detected in all of 24 cytogenetic Philad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2cfd40bc07c5b8d1ac27612b7e776f0
https://doi.org/10.1016/s0304-3835(97)00472-2
https://doi.org/10.1016/s0304-3835(97)00472-2
Publikováno v:
Chemico-Biological Interactions. 104:55-64
Many chemicals have recently been discovered to have estrogenic activity, including the surfactant intermediate nonylphenol (NP). It has been well documented that estrogen is a facilitator of human breast cancer development under certain conditions,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a44a2160e22cab11b5bd12c31ffbedd
https://doi.org/10.1016/s0009-2797(97)03767-8
https://doi.org/10.1016/s0009-2797(97)03767-8
Publikováno v:
Chemico-Biological Interactions. 102:63-67
During our studies on the effects of environmental estrogenic chemicals on vitellogenin gene expression in fish, dimethyl formamide (DMFA) and ethylene glycol (EG) were used as solvents to dissolve and deliver hydrophobic β-estradiol or nonylphenol.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f091839787395804755e24451fd5711
https://doi.org/10.1016/0009-2797(96)03727-1
https://doi.org/10.1016/0009-2797(96)03727-1
Publikováno v:
Chemico-Biological Interactions. 100:67-76
Estrogenic chemicals have drawn considerable attention over the past several years because they are known to be responsible for increased breast and prostate cancer [1,2]. Vitellogenin expression driven by estrogen has been becoming a model for study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d54b656994f574efa849b26a8ef7b6b
https://doi.org/10.1016/0009-2797(95)03686-5
https://doi.org/10.1016/0009-2797(95)03686-5
Autor:
Zhangmin Liang, Jiasen Xu, Zhiping Cai, Jianping Xu, Jiaying He, Lifen Ren-Heidenreich, Xiaodi Luo, Jiaxin Chen, Huiyi Yang
Publikováno v:
Cancer biomarkers : section A of Disease markers. 10(2)
The prevalence of EGFR, KRAS, BRAF and PIK3CA somatic mutations in 861 randomly selected Chinese patients with non-small cell lung cancer (NSCLC) was assayed by the SurPlex -xTAG70plex platform and analyzed. The results showed that the occurrence rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e696eb732a86355b81fd30c1f15249
https://pubmed.ncbi.nlm.nih.gov/22430133
https://pubmed.ncbi.nlm.nih.gov/22430133
Autor:
Gang Yu, Guoqiang Li, Jiaying He, Tao Zeng, Jiasen Xu, Qin Huijuan, Liu Zhiming, Zeyao Zhu, Lifen Ren-Heidenreich, Xiaodi Luo, Shiyang Wu
Publikováno v:
Clinical chemistry and laboratory medicine. 49(2)
Background: DNA somatic mutations of EGFR, KRAS, BRAF and PIK3CA in the epidermal growth factor receptor (EGFR) signaling pathway play critical roles in the response or resistance of tumors to targeted therapy with tyrosine kinase inhibitors (EGFR-TK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48d0b8bc61231e3f2874048399d8d0f
https://pubmed.ncbi.nlm.nih.gov/21118047
https://pubmed.ncbi.nlm.nih.gov/21118047